Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDActual EPS
NKGen Biotech, Inc. Common Stock Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|
NKGen Biotech, Inc. Common Stock Earnings Date And Information
NKGen Biotech, Inc. Common Stock last posted its earnings results on N/A. The company reported $N/A earnings per share for the quarter, missing analysts' consensus estimates of $N/A by $0. The company had revenue of 0 for the quarter and had revenue of 0 for the year. NKGen Biotech, Inc. Common Stock has generated $-5 earnings per share over the last year ($-5.38 diluted earnings per share) and currently has a price-to-earnings ratio of -0.08. NKGen Biotech, Inc. Common Stock has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, April 15th, 2025 based on prior year's report dates.
NKGen Biotech, Inc. Common Stock Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 09/30/2024 | Q3 2024 | N/A | $0.22 | N/A | $0 | $0 |
| 06/29/2024 | Q2 2024 | N/A | -$0.67 | N/A | $0 | $0 |
| 03/30/2024 | Q1 2024 | N/A | -$0.25 | N/A | N/A | $0 |
| 12/30/2023 | Q4 2023 | N/A | -$1.54 | N/A | N/A | $0 |
| 09/29/2023 | Q3 2023 | N/A | -$2.48 | N/A | N/A | $0 |
| 06/28/2023 | Q2 2023 | N/A | -$0.11 | N/A | N/A | $0 |
| 03/29/2023 | Q1 2023 | N/A | $0.02 | N/A | N/A | $0 |
| 12/29/2022 | Q4 2022 | N/A | -$0.14 | N/A | N/A | $0 |
| 09/28/2022 | Q3 2022 | N/A | $0.04 | N/A | N/A | $3,000 |
| 06/28/2022 | Q2 2022 | N/A | $0.22 | N/A | N/A | $0 |
| 03/29/2022 | Q1 2022 | N/A | $0.09 | N/A | N/A | $0 |
| 12/29/2021 | Q4 2021 | N/A | -$0.06 | N/A | N/A | $0 |
| 09/28/2021 | Q3 2021 | N/A | $0.22 | N/A | N/A | $0 |
| 06/28/2021 | Q2 2021 | N/A | -$0.20 | N/A | N/A | $0 |
| 03/29/2021 | Q1 2021 | N/A | -$0.00 | N/A | N/A | $0 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
NKGen Biotech, Inc. Common Stock Earnings: FAQ's
NKGen Biotech, Inc. Common Stock has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, April 15th, 2025 based offlast year's report dates.
The conference call for NKGen Biotech, Inc. Common Stock's latest earnings report can be listened to online.
The conference call transcript for NKGen Biotech, Inc. Common Stock's latest earnings report can be read online.
NKGen Biotech, Inc. Common Stock (:NKGN) has a recorded net income of $-82,954,000.NKGen Biotech, Inc. Common Stock has generated $-5.38 earnings per share over the last four quarters.
NKGen Biotech, Inc. Common Stock (:NKGN) has a price-to-earnings ratio of -0.08 and price/earnings-to-growth ratio is -0.